← Return to all swing-trade opportunities
ISRG — Gap-Fill Reversal
Status: Watch
Scanner score: 40.0/100
Why this was flagged
ISRG was identified as a bullish technical setup based on the Gap-Fill Reversal pattern. The scanner found a score of 40.0/100 using trend alignment, momentum, price action, volume, and risk-management rules.
Trade framework
Position-sizing example
These examples use the distance between the reference entry and stop-loss. They do not account for commissions, slippage, taxes, overnight gaps, or your personal account size.
Exit plan
- Stop-loss: Exit if the stop-loss is reached. Do not move the stop farther away to avoid taking the planned loss.
- Target 1: Consider taking partial profit when Target 1 is reached and reducing risk on the remaining shares.
- Target 2 or trailing exit: Consider closing the remaining position at Target 2, or use a disciplined trailing stop only if the trend remains strong.
- Time exit: Reassess or close a trade that fails to progress within the suggested holding window.
Technical chart
Daily closing price with moving averages and planned trade levels. This chart is a screening aid, not a guarantee of future results.
$1,000 educational outcome examples
These examples use a $1,000 position and fractional shares at the midpoint of the entry zone. Actual results can differ because of market gaps, fills, spreads, commissions, taxes, slippage, and changing conditions.
Easy explanation for new investors
Recent news context
This automated review is separate from the technical score. It summarizes recent related articles and does not predict price movement.
Overall context: Neutral (Moderate confidence)
Intuitive Surgical (ISRG) recently reported a strong Q2 with sales and EPS growth, supported by ongoing analyst positive ratings. Recent news highlights a large meta-analysis published in the Annals of Surgery Open, which found statistically significant patient outcome improvements, such as shorter hospital stays, associated with da Vinci procedures. The company also received CE mark approval for Force Feedback instruments and launched over 100 new enhancements for its da Vinci 5 system in Europe. However, recent filings indicate that an executive sold a small amount of stock, and one report notes a recent stock price decline without providing context. The technical setup indicates a Gap-Fill Reversal with a score of 40, suggesting mixed market signals.
Potentially supportive context
- Q2 earnings showed significant sales and EPS growth.
- New meta-analysis across 13 conditions shows statistically significant improvements in patient outcomes for da Vinci surgery.
- CE mark approval for Force Feedback instruments and over 100 new da Vinci 5 enhancements in Europe were announced.
Risks and caution items
- An executive sold $24,671 in company stock via a pre-arranged trading plan.
- Recent reports indicate the stock price declined without clear contextual reasons.
- The technical score is 40, suggesting a mixed or neutral technical setup.
Latest reviewed article: Sep 11, 2026 7:40 pm
Recent related articles
This article examines how High Tide (NASDAQ:HITI), a cannabis stock, is navigating the current challenging market environment characterized by elevated energy costs, firm Treasury yields, and renewed inflation concerns. The analysis focuses on how these macro pressures impact the company's regulatory developments,…
Mark Brosius, EVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical Inc., recently sold $24,671 worth of company stock through a pre-arranged trading plan. The sales occurred on September 8 and 9, 2026, at prices ranging from $350.20 to $361.23…
Medtronic (NYSE: MDT) has raised its fiscal 2027 organic revenue growth outlook and the lower end of its adjusted earnings forecast, driven by strong demand for cardiovascular devices, particularly pulsed field ablation products. While the company's Q1 performance exceeded expectations and new…
Chad Phipps, an insider at Zimmer Biomet (NYSE:ZBH), sold 3,000 shares of the company's stock for approximately $295,050 on September 4th, reducing his direct ownership by 4.4%. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.…
A new meta-analysis, published in Annals of Surgery Open, reveals that da Vinci robotic-assisted surgery offers statistically significant improvements in patient outcomes for 13 common benign conditions compared to traditional laparoscopic and open surgeries. The study, which analyzed over 14 million procedures,…
A new meta-analysis published in Annals of Surgery Open and led by Intuitive Surgical found that da Vinci robotic-assisted surgery is associated with shorter hospital stays and quicker return to work compared to both laparoscopic and open surgeries for 13 common benign…
A new meta-analysis, the largest of its kind, found that da Vinci robotic-assisted surgery showed statistically significant improvements in patient outcomes for 13 common benign conditions compared to laparoscopic and open surgery. Key findings include shorter hospital stays, faster return to work,…
This article states that Intuitive Surgical (ISRG) stock is down today but provides no additional information or context as the content is just "Document". Therefore, the reason for the stock's decline cannot be determined from the provided text.
Important: Some returned articles may describe competitors, industry conditions, or related companies. Open the source before relying on an article.
Scanner confirmations
- Current volume is at least 1.25x the 20-day average volume.
- Price reversed higher after a prior-day gap down and reclaimed the prior close with volume confirmation.